[
  {
    "ts": "2025-09-05T14:07:05+00:00",
    "headline": "Market’s In A Mood For Consolidaton When It Comes To The Hershey Company (HSY), Says Jim Cramer",
    "summary": "We recently published 10 Stocks That Were On Jim Cramer’s Radar As He Warned “It’s Too Early” To Buy. The Hershey Company (NYSE:HSY) is one of the stocks Jim Cramer recently discussed. The Hershey Company (NYSE:HSY)’s stock has weathered the storm that has hit the broader packaged food sector, as it is up by 9.3% year-to-date. […]",
    "url": "https://finance.yahoo.com/news/market-mood-consolidaton-comes-hershey-140705354.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e62440b7-83e9-3a61-8856-5d09aa685287",
      "content": {
        "id": "e62440b7-83e9-3a61-8856-5d09aa685287",
        "contentType": "STORY",
        "title": "Market’s In A Mood For Consolidaton When It Comes To The Hershey Company (HSY), Says Jim Cramer",
        "description": "",
        "summary": "We recently published 10 Stocks That Were On Jim Cramer’s Radar As He Warned “It’s Too Early” To Buy. The Hershey Company (NYSE:HSY) is one of the stocks Jim Cramer recently discussed. The Hershey Company (NYSE:HSY)’s stock has weathered the storm that has hit the broader packaged food sector, as it is up by 9.3% year-to-date. […]",
        "pubDate": "2025-09-05T14:07:05Z",
        "displayTime": "2025-09-05T14:07:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/b309ba671499a80d9c4a199da0c0d540",
          "originalWidth": 1920,
          "originalHeight": 1271,
          "caption": "Market's In A Mood For Consolidaton When It Comes To The Hershey Company (HSY), Says Jim Cramer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kx5m8vHU6rYBICj7HXebVg--~B/aD0xMjcxO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/b309ba671499a80d9c4a199da0c0d540.cf.webp",
              "width": 1920,
              "height": 1271,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zu9TtkEk6PUZopVyMMxzJA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/b309ba671499a80d9c4a199da0c0d540.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-mood-consolidaton-comes-hershey-140705354.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-mood-consolidaton-comes-hershey-140705354.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSY"
            },
            {
              "symbol": "SJM"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CPB"
            },
            {
              "symbol": "GIS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-05T14:06:39+00:00",
    "headline": "Jim Cramer Says You Don’t Have Anything For General Mills, Inc. (GIS) Unless It Combines With Kraft-Heinz",
    "summary": "We recently published 10 Stocks That Were On Jim Cramer’s Radar As He Warned “It’s Too Early” To Buy. General Mills, Inc. (NYSE:GIS) is one of the stocks Jim Cramer recently discussed. General Mills, Inc. (NYSE:GIS) is one of the largest packaged food products firms in America. Its shares have lost 22% year-to-date as the firm […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-don-t-140639708.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "000b5b18-6e12-3625-b846-7625d6b58346",
      "content": {
        "id": "000b5b18-6e12-3625-b846-7625d6b58346",
        "contentType": "STORY",
        "title": "Jim Cramer Says You Don’t Have Anything For General Mills, Inc. (GIS) Unless It Combines With Kraft-Heinz",
        "description": "",
        "summary": "We recently published 10 Stocks That Were On Jim Cramer’s Radar As He Warned “It’s Too Early” To Buy. General Mills, Inc. (NYSE:GIS) is one of the stocks Jim Cramer recently discussed. General Mills, Inc. (NYSE:GIS) is one of the largest packaged food products firms in America. Its shares have lost 22% year-to-date as the firm […]",
        "pubDate": "2025-09-05T14:06:39Z",
        "displayTime": "2025-09-05T14:06:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/c0eff74d2757740f7bd50f62b79d1d14",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Jim Cramer Says You Don't Have Anything For General Mills, Inc. (GIS) Unless It Combines With Kraft-Heinz",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_bKwwiqKqptEt7dRAbXHog--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c0eff74d2757740f7bd50f62b79d1d14.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9IYoMyZfp_CDZH15rYfaow--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/c0eff74d2757740f7bd50f62b79d1d14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-don-t-140639708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-don-t-140639708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GIS"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CPB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-05T10:20:24+00:00",
    "headline": "Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug",
    "summary": "Led by the former CEO of Hi-Bio and backed by notable investors, the startup licensed from Hengrui a drug it claims is superior to Bristol Myers' Camzyos as well as other, similar medicines.",
    "url": "https://www.biopharmadive.com/news/braveheart-hengrui-hypertrophic-cardiomyopathy-china-licensing-deal/759365/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "ae27cf34-e429-3f96-8ff7-b3a3e451e46f",
      "content": {
        "id": "ae27cf34-e429-3f96-8ff7-b3a3e451e46f",
        "contentType": "STORY",
        "title": "Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug",
        "description": "",
        "summary": "Led by the former CEO of Hi-Bio and backed by notable investors, the startup licensed from Hengrui a drug it claims is superior to Bristol Myers' Camzyos as well as other, similar medicines.",
        "pubDate": "2025-09-05T10:20:24Z",
        "displayTime": "2025-09-05T10:20:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/4ea2287e6f0ca369da9d9f7ac4b84c92",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "An anatomical model of the heart sits on a desk in a doctor's office.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vtWZbOchIizXbsHdLtnp9Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/4ea2287e6f0ca369da9d9f7ac4b84c92.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4mQRmhnjvNp8E4oPOsv7.Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/4ea2287e6f0ca369da9d9f7ac4b84c92.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/braveheart-hengrui-hypertrophic-cardiomyopathy-china-licensing-deal/759365/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bravehart-stealthy-startup-looks-china-102024814.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "600276.SS"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]